Dylan Cole, DO | |
476 Williams Way, Suite A, Moab, UT 84532-2065 | |
(435) 259-7121 | |
(435) 259-3112 |
Full Name | Dylan Cole |
---|---|
Gender | Male |
Speciality | Family Practice |
Experience | 13 Years |
Location | 476 Williams Way, Moab, Utah |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1356636609 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207Q00000X | Family Medicine | 9074848-1204 (Utah) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Cns Community Hospice - Price | Price, UT | Hospice |
Moab Regional Hospital | Moab, UT | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Moab Valley Healthcare Inc | 2466361720 | 12 |
News Archive
The Multiple Sclerosis Association of America (MSAA) received four communications awards, which included two APEX Awards and two National Health Information Awards.
The top executive of Wellpoint, a major health insurer, called for health reform at a meeting of the Economic Club in Indianapolis Tuesday, WTHR, the local NBC affiliate, reports. "The high and rising cost of health care in America is just not sustainable …" said CEO Angela Braly. Those costs pose "a real threat to the social and fiscal obligations of the government and to the health and prosperity of the American people."
In an effort to further individualize therapy and avoid over-treating patients, researchers at the Johns Hopkins Kimmel Cancer Center report a new study using PET scans has identified a biomarker that may accurately predict which patients with one type of HER2-positive breast cancer might best benefit from standalone HER2-targeted agents, without the need for standard chemotherapy.
Ocrelizumab (OCR) is a humanized monoclonal antibody that selectively targets CD20+B cells. In a randomized, double-blind, placebo-controlled Phase III study (ORATORIO), OCR significantly reduced disease activity in patients with primary progressive multiple sclerosis (PPMS).
› Verified 6 days ago
Entity Name | Moab Valley Healthcare Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1770513236 PECOS PAC ID: 2466361720 Enrollment ID: O20040114000346 |
News Archive
The Multiple Sclerosis Association of America (MSAA) received four communications awards, which included two APEX Awards and two National Health Information Awards.
The top executive of Wellpoint, a major health insurer, called for health reform at a meeting of the Economic Club in Indianapolis Tuesday, WTHR, the local NBC affiliate, reports. "The high and rising cost of health care in America is just not sustainable …" said CEO Angela Braly. Those costs pose "a real threat to the social and fiscal obligations of the government and to the health and prosperity of the American people."
In an effort to further individualize therapy and avoid over-treating patients, researchers at the Johns Hopkins Kimmel Cancer Center report a new study using PET scans has identified a biomarker that may accurately predict which patients with one type of HER2-positive breast cancer might best benefit from standalone HER2-targeted agents, without the need for standard chemotherapy.
Ocrelizumab (OCR) is a humanized monoclonal antibody that selectively targets CD20+B cells. In a randomized, double-blind, placebo-controlled Phase III study (ORATORIO), OCR significantly reduced disease activity in patients with primary progressive multiple sclerosis (PPMS).
› Verified 6 days ago
Mailing Address | Practice Location Address |
---|---|
Dylan Cole, DO 476 Williams Way, Suite A, Moab, UT 84532-2065 Ph: (435) 259-7121 | Dylan Cole, DO 476 Williams Way, Suite A, Moab, UT 84532-2065 Ph: (435) 259-7121 |
News Archive
The Multiple Sclerosis Association of America (MSAA) received four communications awards, which included two APEX Awards and two National Health Information Awards.
The top executive of Wellpoint, a major health insurer, called for health reform at a meeting of the Economic Club in Indianapolis Tuesday, WTHR, the local NBC affiliate, reports. "The high and rising cost of health care in America is just not sustainable …" said CEO Angela Braly. Those costs pose "a real threat to the social and fiscal obligations of the government and to the health and prosperity of the American people."
In an effort to further individualize therapy and avoid over-treating patients, researchers at the Johns Hopkins Kimmel Cancer Center report a new study using PET scans has identified a biomarker that may accurately predict which patients with one type of HER2-positive breast cancer might best benefit from standalone HER2-targeted agents, without the need for standard chemotherapy.
Ocrelizumab (OCR) is a humanized monoclonal antibody that selectively targets CD20+B cells. In a randomized, double-blind, placebo-controlled Phase III study (ORATORIO), OCR significantly reduced disease activity in patients with primary progressive multiple sclerosis (PPMS).
› Verified 6 days ago
Kenneth Lewis Williams, M.D. Family Medicine Medicare: Medicare Enrolled Practice Location: 476 Williams Way, Ste A, Moab, UT 84532 Phone: 435-259-7121 Fax: 435-259-3112 | |
Paul Michael Johnson, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 450 Williams Way, Moab, UT 84532 Phone: 435-719-3500 | |
Mr. Ray Allen Andrew, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 255 Williams Way, Moab, UT 84532 Phone: 435-259-4466 | |
Dr. Donald Nilan Marquardt, PHD, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 267 N Main St, Moab, UT 84532 Phone: 435-259-5276 Fax: 435-259-5277 | |
Steven V Rouzer, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 380 North 500 West, Moab, UT 84532 Phone: 435-259-0408 Fax: 435-259-0448 | |
Dr. Patrick Mark Scherer, D.O. Family Medicine Medicare: Medicare Enrolled Practice Location: 450 Williams Way, Moab, UT 84532 Phone: 435-719-3500 |